Chimerix Inc (CMRX)
0.94
+0.04
(+3.98%)
USD |
NASDAQ |
Apr 18, 16:00
0.94
0.00 (0.00%)
After-Hours: 20:00
Chimerix Cash from Operations (TTM): -69.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -69.09M |
September 30, 2023 | -74.49M |
June 30, 2023 | -49.43M |
March 31, 2023 | -45.64M |
December 31, 2022 | -46.87M |
September 30, 2022 | -60.90M |
June 30, 2022 | -83.32M |
March 31, 2022 | -85.48M |
December 31, 2021 | -99.93M |
September 30, 2021 | -74.95M |
June 30, 2021 | -67.96M |
March 31, 2021 | -63.11M |
December 31, 2020 | -36.04M |
September 30, 2020 | -30.46M |
June 30, 2020 | -64.32M |
March 31, 2020 | -70.27M |
December 31, 2019 | -75.18M |
September 30, 2019 | -80.01M |
June 30, 2019 | -50.73M |
March 31, 2019 | -50.95M |
December 31, 2018 | -53.72M |
September 30, 2018 | -57.55M |
June 30, 2018 | -56.05M |
Date | Value |
---|---|
March 31, 2018 | -55.01M |
December 31, 2017 | -50.12M |
September 30, 2017 | -47.70M |
June 30, 2017 | -49.25M |
March 31, 2017 | -48.80M |
December 31, 2016 | -63.82M |
September 30, 2016 | -87.04M |
June 30, 2016 | -99.04M |
March 31, 2016 | -109.50M |
December 31, 2015 | -99.71M |
September 30, 2015 | -83.66M |
June 30, 2015 | -70.18M |
March 31, 2015 | -56.80M |
December 31, 2014 | -47.08M |
September 30, 2014 | -36.99M |
June 30, 2014 | -30.68M |
March 31, 2014 | -28.63M |
December 31, 2013 | -25.56M |
September 30, 2013 | -23.42M |
June 30, 2013 | -5.919M |
March 31, 2013 | -3.014M |
December 31, 2012 | -1.876M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-99.93M
Minimum
Dec 2021
-30.46M
Maximum
Sep 2020
-64.64M
Average
-67.96M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
UFP Technologies Inc | 41.33M |
Dentsply Sirona Inc | 377.00M |
Arbutus Biopharma Corp | -85.94M |
Pacira BioSciences Inc | 154.65M |
Karyopharm Therapeutics Inc | -92.72M |